Join us Sept. 14-16 in Miami to connect with top publishing leaders
Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
Carhartt aligns with the NFL through the tradespeople building Highmark Stadium
Carhartt is finding a way to tap into football season that goes beyond partnering with the athletes themselves.
Future of Marketing Briefing: Soccer’s World Cup buzz isn’t moving needle on Premier League ad spend
The World Cup was a success for broadcasters, but marketers looking to capitalize on rising interest in soccer must navigate a diffuse landscape of sporting properties and fan identities.
Three years after Kokai, The Trade Desk is betting on refinement with Zuma
The Trade Desk wants Zuma — the next version of its programmatic platform, Kokai — to be easier to use, and even harder to leave.